Data Integrity: A Global Regulatory Survey

Wednesday, October 10, 2018 - 11:00am


This webinar will survey the recent regulatory findings concerning data integrity, establish the importance of data integrity to GMP compliance & compare the content of the data integrity guidance from FDA, MHRA, EMA, WHO, and PIC/S. 

Learning Objectives

  • Describe the importance of data integrity to GMP compliance }
  • Discuss the impact of regulatory issues resulting from lack of data integrity }
  • Identify major differences between several recently issued regulatory guidance }
  • Identify the clauses of the NSF/IPEC/ANSI 363 excipient GMP Standard that require data integrity


Dale Carter

Dale headshot
Director, Global Quality
J M Huber, Engineered Materials, Silica Business unit

Dale is the Global Director of Quality for the Silica Business Unit of Huber Engineered Materials and past chair of IPEC-Americas. He is responsible for quality systems, product quality and compliance with IPEC/PQG GMPs for the manufacturing of Silica products at facilities in Tennessee, Maryland, India, Finland, and China. Dale has been performing risk assessments for over 20 years in both food and pharmaceutical ingredients. He has been a member of the EXCiPACT ™ Board and NSF Joint Committee on Pharmaceutical Excipients.

Prior to joining Huber, he was the Manager, Product Quality and Management Systems in the Office of Compliance and Ethics for the Archer Daniels Midland Company where he supported processing and business operations in the development and improvement of quality management systems to ensure sustainable quality, regulatory compliance, effective risk management, and customer satisfaction. While with ADM he supported excipients, bulk APIs, food ingredients, dietary supplement ingredients, biofuels, animal feeds, and specialty grains products.

He holds a Bachelor of Science degree from Davidson College in Chemistry and a Master of Science degree in Chemistry from North Carolina State University.


Janeen SkutnikWilkinson

Regulatory Intelligence and Pharmacopoeial Affairs

Ms. Skutnik-Wilkinson is currently with BIOGEN where she is responsible for Regulatory Intelligence and Pharmacopoeial Affairs (a role similar to her Pfizer role detailed here). Previously she was the Vice President of NSF Health Sciences Pharma-Biotech. Before that, she was the Director of Quality Strategy at Pfizer, and was responsible for working with various trade associations and also developing Pfizer Positions on Quality and CMC issues on a global scale. Janeen has over 22 years of experience and expertise in compendial activities, quality and regulatory policy. She also has held a variety of positions spanning from responsibilities in documentation, change control, analytical method validation, and product launch. Ms. Skutnik-Wilkinson earned a Bachelors of Science from the University of Connecticut in 1994. Ms. Skutnik-Wilkinson is Past-Chair of the International Pharmaceutical Excipients Federation (IPEC Fed). She is also past-Chair of IPEC-Americas and served as Chair of IPEC Compendial Review/Harmonization Workgroup (1999 – 2007). She sits on the ICH Assembly (formerly known as the steering committee) as a representative for IPEC Federation, and is also actively involved in PDA, PhRMA and BPOG.

Cancellation Policy


Cancellations for live webinars must be made in writing and can be mailed or e-mailed to:

IPEC-Americas Webinars
3138 10th Street N
Arlington, VA 22201
Suite 500

Registration fees are refundable for attendees registered for individual webinars, if cancellation is received at least five (5) business days prior to the course. Notices of cancellation received 0-4 business days prior to the course will not be provided a refund. If you registered and are unable to attend the webinar, a recording of the webinar will be provided.

No cancellations are available for webcasts (archived recorded webinars). Recordings are available for 21 days after purchase.

Please contact IPEC-Americas Training Coordinator
571-814-3450 or email